Novo’s Wegovy Shows Stronger Weight-Loss Effects in Women Than Men: Study

cafead

Administrator
Staff member
  • cafead   Jun 24, 2024 at 11:32: AM
via Novo Nordisk’s blockbuster obesity treatment Wegovy (semaglutide) induced greater weight loss in women than in men with a common type of heart failure, according to research presented Sunday at the American Diabetes Association’s 2024 Scientific Sessions and published in the Journal of the American College of Cardiology.

article source
 

<